Director/PDMR Shareholding

RNS Number : 6302A
AstraZeneca PLC
02 April 2012
 



Transactions by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

On 30 March 2012, the following individuals, who are all persons discharging managerial responsibilities, were each granted awards under the terms of the AstraZeneca Investment Plan (AZIP) and the AstraZeneca Performance Share Plan (AZPSP) over the Company's ordinary shares, or, in the case of David Smith, Lynn Tetrault and Tony Zook, over the Company's American Depositary Shares (ADSs).  One ADS equals one ordinary share.  A summary of these plans can be found in the AstraZeneca Annual Report and Form 20-F Information 2011 which is available on the Company's website www.astrazeneca.com.

 

 

Name

Shares awarded under AZIP

Shares awarded under AZPSP

Award price per share

 

Katarina Ageborg

 

3,291

 

19,747

 

2805p

 

Martin Mackay

 

16,764

 

100,588

 

2805p

 

Jeff Pott

 

8,975

 

53,850

 

2805p

 

David Smith

 

8,306

 

49,841

 

$44.82

 

Lynn Tetrault

 

7,194

 

43,168

 

$44.82

 

Tony Zook

 

16,669

 

100,014

 

$44.82

 

The AZIP award is subject to a four-year performance period (1 January 2012 to 31 December 2015) and a subsequent four-year holding period (1 January 2016 to 31 December 2019). The performance hurdle that applies to the AZIP award relates to dividends and dividend cover.

 

The AZPSP award is subject to a three-year performance period (1 January 2012 to 31 December 2014). The performance measures that apply to the AZPSP award relate to relative total shareholder return and cash flow.

 

 

A C N Kemp

Company Secretary

2 April 2012

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUURSRUBASRAR

Companies

AstraZeneca (AZN)
UK 100